AstraZeneca staffers detained in China over patient data collection, drug imports

AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case.

Five current and former employees of AstraZeneca have been detained in China over possible violation of data privacy laws and illegal importation of unapproved drugs, Bloomberg reports, citing people familiar with the matter. No formal arrests—a separate, more serious step in the Chinese judicial system—have been announced.